Zacks.com on MSN22 小时
ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
Shares of Aclaris Therapeutics ACRS rallied 53.2% on Monday and gained another 8.9% during the after-market hours following ...